Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
ANDEMBRY Inj Lös 200 mg 1 Stk
Drug
Andembry, Injektionslösung im Fertigpen
Langzeitprophylaxe wiederkehrender akuter Schübe des hereditären Angioödems (HAE) bei erwachsenen und pädiatrischen Patienten ab 12 Jahren.
02.99.0. – various
HAM – Human medicine
INLFP – Solution for injection in pre-filled pen
BT – biological medicines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
2/24/2025
2/23/2030
Dosage strength
Andembry 200 mg, Injektionslösung im Fertigpen
Langzeitprophylaxe wiederkehrender akuter Schübe des hereditären Angioödems (HAE) bei erwachsenen und pädiatrischen Patienten ab 12 Jahren.
01
Z – approved
Package
7680695530018
In trade (7/1/2025 - 1/1/2040)
A/R – Authorised / referenced
1
001
Z – approved
Declaration
Component
200 mg garadacimabum
histidinum
arginini hydrochloridum
prolinum
polysorbatum 80
aqua ad iniectabile
arginini hydrochloridum
prolinum
polysorbatum 80
aqua ad iniectabile
Spezialitätenliste***
GGSL
-
-
16158.45
None
Yes
10%
No
Authorisation holder
7601001358294
CSL Behring AG
Wankdorfstrasse 10
3014 Bern (BE)
Wankdorfstrasse 10
3014 Bern (BE)
Date of revision of the text
9/4/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.